1. Home
  2. BHFAN vs RLAY Comparison

BHFAN vs RLAY Comparison

Compare BHFAN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

BHFAN

Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

HOLD

Current Price

$11.69

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

N/A

Current Price

$18.62

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BHFAN
RLAY
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
4.1B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
BHFAN
RLAY
Price
$11.69
$18.62
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$19.50
AVG Volume (30 Days)
47.7K
2.2M
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
23.06
31.78
EPS
2.84
N/A
Revenue
$6,766,000,000.00
$15,355,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$324.03
P/E Ratio
$4.15
N/A
Revenue Growth
43.23
53.44
52 Week Low
$10.95
$3.89
52 Week High
$14.44
$21.27

Technical Indicators

Market Signals
Indicator
BHFAN
RLAY
Relative Strength Index (RSI) 52.49 45.13
Support Level $10.97 $18.00
Resistance Level $11.84 $20.82
Average True Range (ATR) 0.21 0.80
MACD 0.04 -0.13
Stochastic Oscillator 66.27 28.24

Price Performance

Historical Comparison
BHFAN
RLAY

About BHFAN Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: